MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Completed · Phase 3 · Has a placebo group

Conditions studied: COVID-19

In brief

This study looks at the safety and effectiveness of MP0420 in treating COVID-19 in people who have been hospitalized with the infection. Participants in the study will be treated with either MP0420 plus current standard of care (SOC), or with placebo plus current SOC. This is ACTIV-3/TICO Treatment Trial H5.

Key facts

Study ID
NCT05780463
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
People needed
485
Starts
2021-06-11
Expected to finish
2023-06-08
Last updated by the study team
2024-02-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.